Logo image of GCTS

GCT SEMICONDUCTOR HOLDING IN (GCTS) Stock Fundamental Analysis

NYSE:GCTS - New York Stock Exchange, Inc. - US36170N1072 - Common Stock - Currency: USD

1.38  +0.04 (+2.99%)

After market: 1.38 0 (0%)

Fundamental Rating

1

GCTS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. GCTS has a bad profitability rating. Also its financial health evaluation is rather negative. GCTS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GCTS has reported negative net income.
In the past year GCTS has reported a negative cash flow from operations.
GCTS Yearly Net Income VS EBIT VS OCF VS FCFGCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

1.2 Ratios

With a Return On Assets value of -115.04%, GCTS is not doing good in the industry: 94.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -115.04%
ROE N/A
ROIC N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTS Yearly ROA, ROE, ROICGCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

The Gross Margin of GCTS (50.50%) is better than 62.73% of its industry peers.
GCTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTS Yearly Profit, Operating, Gross MarginsGCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

GCTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GCTS has more shares outstanding
The debt/assets ratio for GCTS has been reduced compared to a year ago.
GCTS Yearly Shares OutstandingGCTS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GCTS Yearly Total Debt VS Total AssetsGCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

GCTS has an Altman-Z score of -53.68. This is a bad value and indicates that GCTS is not financially healthy and even has some risk of bankruptcy.
GCTS's Altman-Z score of -53.68 is on the low side compared to the rest of the industry. GCTS is outperformed by 87.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -53.68
ROIC/WACCN/A
WACC11.93%
GCTS Yearly LT Debt VS Equity VS FCFGCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.22 indicates that GCTS may have some problems paying its short term obligations.
GCTS has a worse Current ratio (0.22) than 98.18% of its industry peers.
A Quick Ratio of 0.17 indicates that GCTS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.17, GCTS is doing worse than 98.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.17
GCTS Yearly Current Assets VS Current LiabilitesGCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GCTS have decreased strongly by -41.32% in the last year.
GCTS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.69%.
EPS 1Y (TTM)-41.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-951.16%
Revenue 1Y (TTM)-14.69%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.81%

3.2 Future

GCTS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.00% yearly.
Based on estimates for the next years, GCTS will show a very strong growth in Revenue. The Revenue will grow by 135.34% on average per year.
EPS Next Y-60%
EPS Next 2Y31.66%
EPS Next 3Y32%
EPS Next 5YN/A
Revenue Next Year122.97%
Revenue Next 2Y215.83%
Revenue Next 3Y135.34%
Revenue Next 5YN/A

3.3 Evolution

GCTS Yearly Revenue VS EstimatesGCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
GCTS Yearly EPS VS EstimatesGCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GCTS. In the last year negative earnings were reported.
Also next year GCTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTS Price Earnings VS Forward Price EarningsGCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTS Per share dataGCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

GCTS's earnings are expected to grow with 32.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.66%
EPS Next 3Y32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GCTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GCT SEMICONDUCTOR HOLDING IN

NYSE:GCTS (7/14/2025, 8:04:01 PM)

After market: 1.38 0 (0%)

1.38

+0.04 (+2.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-12 2025-08-12
Inst Owners13.54%
Inst Owner Change0%
Ins Owners3.56%
Ins Owner Change-22.87%
Market Cap76.96M
Analysts82.86
Price Target4.59 (232.61%)
Short Float %3.77%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.48%
Min EPS beat(2)-47.06%
Max EPS beat(2)28.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-43.95%
Min Revenue beat(2)-74.04%
Max Revenue beat(2)-13.85%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.27%
EPS NY rev (1m)-92%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-43.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS0.11
BVpS-1.18
TBVpS-1.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -115.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.5%
FCFM N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.4%
Cap/Sales 10.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.17
Altman-Z -53.68
F-Score2
WACC11.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-951.16%
EPS Next Y-60%
EPS Next 2Y31.66%
EPS Next 3Y32%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.69%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.81%
Revenue Next Year122.97%
Revenue Next 2Y215.83%
Revenue Next 3Y135.34%
Revenue Next 5YN/A
EBIT growth 1Y-80.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.42%
EBIT Next 3Y50.09%
EBIT Next 5YN/A
FCF growth 1Y-1928.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1875.4%
OCF growth 3YN/A
OCF growth 5YN/A